Dong, Zhe
Wang, Gao-Yuan
Dai, Dong-Yu
Qin, Guan-Jie
Tang, Ling-Long
Xu, Cheng
Ma, Jun
Funding for this research was provided by:
Cancer Innovative Research Program of Sun Yat-sen University Cancer Center (CIRP-SYSUCC-0005, CIRP-SYSUCC-0005, CIRP-SYSUCC-0005, CIRP-SYSUCC-0005, CIRP-SYSUCC-0005, CIRP-SYSUCC-0005, CIRP-SYSUCC-0005)
Article History
Received: 6 January 2024
Accepted: 26 March 2024
First Online: 15 April 2024
Change Date: 25 April 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12885-024-12276-9
Declarations
:
: The authors declare no competing interests.
: The study protocol approval by the institutional ethics committee. Informed consent was waived as the study only involved the retrospective inclusion of deidentified data.
: Not applicable.
: FDG Fluorodeoxyglucose.PET/CT Positron emission tomography/computed tomography.lrNPC Locoregional recurrent nasopharyngeal.r Recurrent/recurrence.OS Overall survival.HR Hazard ratio.MRI Magnetic resonance imaging.IMRT Intensity-modulated radiotherapy.IC Induction chemotherapy.VS Versus.CT Computed tomography.LDH Lactate dehydrogenase.CRP C-reactive protein.ALB Albumin.EBV Epstein-Barr virus.FSE Fast spin-echo.TR Repetition time.TE Echo time.2D Two dimensions.3D Three dimensions.AUC Area under the curve.ROC Receiver operating characteristic.IQR Interquartile range.SUVmax Maximum standardized uptake value.UICC/AJCC Union for International Cancer Control/American Joint Committee. on Cancer.MTV Metabolic tumor volume.TLG Total lesion glycolysis.